759
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Role of microRNA-449a in the progress of inflammatory bowel disease in children

, , , , &
Pages 144-153 | Received 26 Sep 2019, Accepted 29 Jan 2020, Published online: 12 Feb 2020

References

  • Wehkamp J, Götz M, Herrlinger K, et al. Inflammatory bowel disease. Dtsch Arztebl Int. 2016;113(5):72–82.
  • Engel MA, Khalil M, Neurath MF. Highlights in inflammatory bowel disease-from bench to bedside. Clin Chem Lab Med. 2012;50(7):1229–1235.
  • Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–727.
  • Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’ s and colitis epidemiology study. Gastroenterology 2013;145(1):158–165.e2.
  • Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016;14(2):111–119.
  • Want XQ, Zhan BY, Xu CD, et al. Inflammatory bowel disease in Chinese children. Intest Res 2016;14(2):111–119.
  • Hevman MB, Iirschner BS, Gold BD, et al. Children with early onset inllammatoxy bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005;146(1):35–40.
  • Matney SA, Avant K, Staggers N. Toward an understanding of wisdom in nursing. Online J Issues Nurs. 2015;21(1):9. DOI: 10.1016/j.jpeds.2004.08.043.
  • Luo D, Lin Z. Research progress on wisdom nursing model in nursing intervention of inflammatory bowel disease. Chin Nurs Res 2017;31:3767–3772.
  • Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev. 2015;87:3–14.
  • Soifer HS, Rossi JJ, Saetrom P. MicroRNAs in disease and potential therapeutic applications. Mol Ther. 2007;15(12):2070–2079.
  • Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597–610.
  • O’Connell RM, Rao DS, Chaudhuri AA. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 2010;10(2):111–122.
  • Ghorpade DS, Sinha AY, Holla S, et al. NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease. J Biol Chem. 2013;288(46):33037–33048.
  • Maharshak N, Shenhar-Tsarfaty S, Aroyo N, et al. MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(7):1346–1353.
  • Olaru AV, Yamanaka S, Vazquez C, et al. MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(3):471–480.
  • Schönauen K, Le N, von Arnim U, et al. Circulating and fecal microRNAs as biomarkers for inflammatory bowel diseases. Inflamm Bowel Dis. 2018;24(7):1547–1557.
  • De Iudicibus S, Lucafò M, Vitulo N, et al. High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients. Int J Mol Sci 2018;19(5):1399.
  • Whiteoak SR, Felwick R, Sanchez-Elsner T, et al. MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities. Inflamm Bowel Dis. 2015;21(5):1160–1165.
  • Mohammadi A, Kelly OB, Filice M, et al. Differential expression of microRNAs in peripheral blood mononuclear cells identifies autophagy and TGF-beta-related signatures aberrantly expressed in inflammatory bowel disease. J Crohns Colitis. 2018;12(5):568–581.
  • Gupta S, Silveira DA, Mombach J. Modeling the role of microRNA-449a in the regulation of the G2/M cell cycle checkpoint in prostate LNCaP cells under ionizing radiation. PLoS One. 2018;13(7):e0200768.
  • Wu J, Zou M, Ping A, et al. MicroRNA-449a upregulation promotes chondrocyte extracellular matrix degradation in osteoarthritis. Biomed Pharmacother. 2018;105:940–946.
  • Han R, Ji X, Rong R, et al. MiR-449a regulates autophagy to inhibit silica-induced pulmonary fibrosis through targeting Bcl2. J Mol Med. 2016;94(11):1267–1279.
  • Nighot P, Young K, Nighot M, et al. Chloride channel ClC-2 is a key factor in the development of DSS-induced murine colitis. Inflamm Bowel Dis. 2013;19(13):2867–2877.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25(4):402–408.
  • Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17(6):1314–1321.
  • Liu X, Chen J, Guan T, et al. Correction to: miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson’s disease. BMC Syst Biol. 2019;13(1):20.
  • He YM, Ji AJ, Xu XY, et al. miR-449a: a potential therapeutic agent for cancer. Anticancer Drugs 2017;28(10):1067–1078.
  • Chen W, Liu Y, Chen H, et al. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis. Int J Oncol. 2017;51(2):435–444.
  • Li L, Liu H, Du L, et al. MiR-449a suppresses LDHA-mediated glycolysis to enhance the sensitivity of non-small cell lung cancer cells to ionizing radiation. Oncol Res. 2018;26(4):547–556.
  • Li F, Liang J, Bai L. MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression. Biomed Pharmacother. 2018;103:782–789.
  • Xu B, Zhang X, Wang S, et al. MiR-449a suppresses cell migration and invasion by targeting PLAGL2 in breast cancer. Pathol Res Pract. 2018;214(5):790–795.
  • Zhang C, Ma C, Zhang L, et al. MiR-449a-5p mediates mitochondrial dysfunction and phenotypic transition by targeting Myc in pulmonary arterial smooth muscle cells. J Mol Med. 2019;97(3):409–422.
  • Zeng Q, Jin C, Ao L, et al. Cross-talk between the Toll-like receptor 4 and Notch1 pathways augments the inflammatory response in the interstitial cells of stenotic human aortic valves. Circulation 2012;126(11_suppl_1):S222–S230.
  • Tohda S. NOTCH signaling roles in acute myeloid leukemia cell growth and interaction with other stemness-related signals. Anticancer Res. 2014;34(11):6259–6264.
  • Guo D, Li C, Teng Q, et al. Notch1 overexpression promotes cell growth and tumor angiogenesis in myeloma. Neoplasma 2012;60(01):33–40.
  • Liu R, Tang A, Wang X, et al. Inhibition of lncRNA NEAT1 suppresses the inflammatory response in IBD by modulating the intestinal epithelial barrier and by exosome-mediated polarization of macrophages. J Mol Med 2018;42(5):2903–2913.
  • Kruse ML, Friedrich M, Arlt A, et al. Colonic lamina propria inflammatory cells from patients with IBD induce the nuclear factor-E2 related factor-2 thereby leading to greater proteasome activity and apoptosis protection in human colonocytes. Inflamm Bowel Dis. 2016;22(11):2593–2606.
  • Li M, Zhang S, Qiu Y, et al. Upregulation of miR-665 promotes apoptosis and colitis in inflammatory bowel disease by repressing the endoplasmic reticulum stress components XBP1 and ORMDL3. Cell Death Dis. 2017;8(3):e2699–e2699.
  • Gu L, Ge Z, Wang Y, et al. Activating transcription factor 3 promotes intestinal epithelial cell apoptosis in Crohn’s disease. Pathol Res Pract. 2018;214(6):862–870.
  • Cai Y, Jiang C, Zhu J, et al. miR-449a inhibits cell proliferation, migration, and inflammation by regulating high-mobility group box protein 1 and forms a mutual inhibition loop with Yin Yang 1 in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Res Ther. 2019; 21(1):134.
  • Zong D, Li J, Cai S, et al. Notch1 regulates endothelial apoptosis via the ERK pathway in chronic obstructive pulmonary disease. Am J Physiol Cell Physiol. 2018;315(3):C330–C340.
  • Zhao NJ, Liao MJ, Wu JJ, et al. Curcumin suppresses Notch‑1 signaling: improvements in fatty liver and insulin resistance in rats. Mol Med Rep. 2018;17(1):819–826.